02/28/2025
4:01 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
9:23 AM | FMR LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/30/2025
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:15 PM | Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
| Form 4/A | |
01/21/2025
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
5:31 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
5:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
6:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:18 PM | CHYUNG YUNG H. (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for KROS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/06/2024
3:22 PM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
4:06 PM | GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
4:01 PM | Keros Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:12 PM | Keros Therapeutics (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:02 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:15 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
06/17/2024
4:17 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
5:07 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:10 PM | BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2024
3:11 PM | BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
3:15 PM | Farzan Nima (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | GRAY MARY ANN (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Knowles Julius (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Nussbaum Ran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Kariv Tomer (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Seth Alpna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:03 AM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
7:00 AM | Keros Therapeutics (Filer)
| Form S-3ASR | |
03/14/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump finally met his match? (Ad) Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again? Click here for his emergency broadcast... |
03/05/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free KROS Stock Alerts